Speaker Profile
Ph.D., Director of the Office of Advanced Molecular Detection (OAMD), CDC
Biography
Duncan MacCannell is the Director of the Office of Advanced Molecular
Detection (OAMD) at the National Center for Emerging and Zoonotic
Infectious Diseases (NCEZID) at the CDC. He has been instrumental in using
emerging next generation sequencing technologies to transform infectious
disease public health, leading to the establishment of the Advanced
Molecular Detection (AMD) Program in 2014. He has guided the program's
development and application of sequencing and high performance computing to
public health priorities such as detecting and responding to outbreaks and
identifying emerging infectious threats. During the pandemic response, Dr.
MacCannell established the CDC SPHERES Consortium, which tracks the spread
and evolution of SARSCoV2, the virus that causes COVID19. He leads the
consortium's efforts to monitor the emergence and spread of new SARSCoV2
variants, which is critical for informing public health decision making,
tracking the evolution of infectious diseases and to inform public health
policy
Session Abstract – PMWC 2027 Silicon Valley
Track Chair:
Christina Curtis, Stanford
PMWC Award Ceremony
• Joe DeRisi, UCSF / CZ Biohub / Delve Bio (Luminary)
• Alexandre Loupy, Inserm / Paris Transplant Group (Pioneer)
Featured Speakers
• Joe DeRisi, UCSF / CZ Biohub / Delve Bio
• Alexandre Loupy, Inserm / Paris Transplant Group
• Minnie Sarwal, UCSF
• Kiran Khush, Stanford
• Iwijn De Vlaminck, Cornell
• Maarten Naesens, KU Leuven
• Charles Chiu, UCSF
• Michael Snyder, Stanford
• Duncan MacCannell, CDC
• Chaz Langelier, UCSF
• Yoel Sadovsky, Stanford
• Ananth Karumanchi, Cedars-Sinai
• Gabriel Bien-Willner, Palmetto GBA / MolDX
• Dawn Cardeiro, Roche Diagnostics
• Bruce Quinn, Bruce Quinn Associates
Transplant & Organ Health Diagnostics
From biopsy to blood-based monitoring of rejection, injury, and infection.
Blood-Based Omics and Host Response in Infection
Metagenomics and host-response signals for difficult infectious disease cases.
Maternal & Fetal Health
From prenatal screening to actionable maternal and placental biomarkers.
From Signal to Standard of Care
What makes a non-cancer blood test clinically actionable and reimbursable.
PMWC Hall of Impact
Previous Speakers Include
Nobel laureates, technology founders, regulators, CEOs and scientific pioneers who have taken the PMWC stage.
